Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002712370 | SCV003549952 | uncertain significance | Inborn genetic diseases | 2022-10-26 | criteria provided, single submitter | clinical testing | The c.625T>A (p.C209S) alteration is located in exon 3 (coding exon 3) of the FAM20A gene. This alteration results from a T to A substitution at nucleotide position 625, causing the cysteine (C) at amino acid position 209 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005021681 | SCV005651054 | uncertain significance | Amelogenesis imperfecta type 1G | 2024-04-10 | criteria provided, single submitter | clinical testing |